Antineoplastic treatment effect on bone mineral density in Mexican breast cancer patients

BMC Cancer

Table 2 Bone Mineral Density (BMD) T-score^a distribution and change at six months of antineoplastic breast cancer treatment. (n = 40)

Menopausal status	Bone region	Normal (T score > -1)	Osteopenia (T score < -1 > 2.5)	Osteoporosis (Tscore < -2.5)
Premenopausal (n = 19)	Femoral neck
	Basal	12	7	-
	6 months treatment	17	2	-
	Lumbar spine (L2-L4)
	Basal	9	7	3
	6 months treatment	4	10	5
Postmenopausal (n = 21)	Femoral neck
	Basal	21	-	-
	6 months treatment	16	5	-
	Lumbar spine (L2-L4)
	Basal	21	-	-
	6 months treatment	21	-	-

Data in table are number of cases
^aWHO cut-off points. T-score is defined as BMD Standard Deviations (SD) respect to 20–39 years old health population of same gender

ISSN: 1471-2407